These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19593618)

  • 1. Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer.
    Kijima Y; Yoshinaka H; Hirata M; Umekita Y; Matsukita S; Arima T; Nakagawa M; Kumemura H; Hamada N; Kaneko K; Funasako Y; Natsugoe S
    Int J Clin Oncol; 2009 Jun; 14(3):249-53. PubMed ID: 19593618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metachronous or synchronous male breast and prostate cancers a duality to lookout for.
    Mukendi AM; Van Den Berg E; Pather S; Padayachee RS
    F1000Res; 2018; 7():1825. PubMed ID: 31431822
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
    Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
    BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancer.
    Vetto JT; Beer TM; Fidda N; Ham B; Jimenez-Lee R; Schmidt W
    Diagn Cytopathol; 2004 Dec; 31(6):417-9. PubMed ID: 15540181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer].
    Emoto A; Nasu N; Mimata H; Nomura Y; Mizokuchi H; Wada M
    Nihon Hinyokika Gakkai Zasshi; 2001 Nov; 92(7):698-701. PubMed ID: 11766369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence?
    Coard K; McCartney T
    South Med J; 2004 Mar; 97(3):308-10. PubMed ID: 15043344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer.
    Uehara S; Yuasa T; Fujii Y; Yano A; Yamamoto S; Masuda H; Fukui I; Yonese J
    BMC Res Notes; 2015 Aug; 8():335. PubMed ID: 26242866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral male breast cancer: too many concerns?
    dos Santos VM; Cintra Osterne EM; de Castro RA; Marques HV
    Asian Pac J Cancer Prev; 2007; 8(4):640-1. PubMed ID: 18260745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A male patient with metachronous triple cancers of small cell lung, prostate and breast.
    Baba M; Higaki N; Ishida M; Kawasaki H; Kasugai T; Wada A
    Breast Cancer; 2002; 9(2):170-4. PubMed ID: 12016398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
    Aksnessæther BY; Solberg A; Klepp OH; Myklebust TÅ; Skovlund E; Hoff SR; Vatten LJ; Lund JÅ
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):211-216. PubMed ID: 29534900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of locally advanced prostate cancer with low serum testosterone associated with intake of an androgenic medicine].
    Sakura M; Tsukamoto T; Yonese J; Nakaishi M; Maezawa T; Takimoto K; Fukui I
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):529-32. PubMed ID: 12795169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
    Karamanakos P; Mitsiades CS; Lembessis P; Kontos M; Trafalis D; Koutsilieris M
    Anticancer Res; 2004; 24(2C):1077-81. PubMed ID: 15154626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort.
    Lu Y; Ljung R; Martling A; Lindblad M
    Cancer Control; 2015 Apr; 22(2):263-70. PubMed ID: 26068776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy combined with androgen-deprivation therapy in high-volume metastatic hormone sensitive prostate cancer: a short-term efficacy and safety analysis].
    Xu PH; Shen YJ; Xiao WJ; Lin GW; Qin XJ; Zhu Y; Dai B; Ye DW
    Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):418-421. PubMed ID: 31142065
    [No Abstract]   [Full Text] [Related]  

  • 15. A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer.
    Moosavi L; Kim P; Uche A; Cobos E
    J Investig Med High Impact Case Rep; 2019; 7():2324709619847230. PubMed ID: 31053047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.
    McKay RR; Zurita AJ; Werner L; Bruce JY; Carducci MA; Stein MN; Heath EI; Hussain A; Tran HT; Sweeney CJ; Ross RW; Kantoff PW; Slovin SF; Taplin ME
    J Clin Oncol; 2016 Jun; 34(16):1913-20. PubMed ID: 27044933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilateral breast metastases from prostatic carcinoma: a case report].
    Soda T; Onishi H; Terachi T; Oishi K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1999 Apr; 45(4):269-71. PubMed ID: 10363149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
    Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
    Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of androgen-deprivation therapy in patients with prostate cancer: A case study.
    Doyle-Lindrud S
    Clin J Oncol Nurs; 2006 Oct; 10(5):565-6. PubMed ID: 17063610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.